Stockscreener 앱 받기
183.83
1.20%
2.18
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
What is Ligand Pharmaceuticals Incorporated’s market positionJuly 2025 Review & High Accuracy Trade Alerts - mfd.ru
Cibc World Market Inc. Increases Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Is Ligand Pharmaceuticals Incorporated in a long term uptrend2025 Major Catalysts & Capital Efficiency Focused Ideas - mfd.ru
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2025 Financial Results Call Scheduled for February 26, 2026 - Quiver Quantitative
Biopharma company Ligand to reveal 2025 results Feb. 26 - Stock Titan
Is Ligand Pharmaceuticals Incorporated subject to activist investor interest2025 Big Picture & Reliable Entry Point Trade Alerts - mfd.ru
Should I buy Ligand Pharmaceuticals Incorporated stock nowJuly 2025 Sector Moves & Capital Efficiency Focused Strategies - mfd.ru
Why Ligand Pharmaceuticals Incorporated stock is a must watch in 2025Profit Target & Stepwise Trade Signal Guides - mfd.ru
Impax Asset Management Group plc Sells 60,000 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Principal Financial Group Inc. Sells 7,210 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Trend Review: Is AMRN a cyclical or defensive stockQuarterly Trade Report & Safe Capital Investment Plans - baoquankhu1.vn
Ranger Investment Management L.P. Has $48.77 Million Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AbbVie (ABBV) and Bio-Techne (TECH) - The Globe and Mail
Ligand Pharmaceuticals (LGND) director sells $91k in stock By Investing.com - Investing.com India
Ligand Pharmaceuticals (LGND) director sells $91k in stock - Investing.com
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus
Ligand Pharmaceuticals (LGND) Valuation Check As Partner Milestones Expand Royalty And Growth Potential - simplywall.st
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Yahoo Finance
Ligand Pharmaceuticals (NASDAQ:LGND) Director John Kozarich Sells 467 Shares - MarketBeat
LGND: New Year Program Updates - Zacks Small Cap Research
Villere ST Denis J & Co. LLC Has $49.59 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
New York State Common Retirement Fund Decreases Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Growth Value: Whats next for Global Business Travel Group Inc stockBuy Signal & Weekly High Potential Stock Alerts - baoquankhu1.vn
Earnings Update: Should you avoid IKNA stock right nowJuly 2025 Pullbacks & Technical Pattern Alert System - baoquankhu1.vn
Published on: 2026-02-02 03:00:22 - baoquankhu1.vn
Lisanti Capital Growth LLC Boosts Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Surprises Report: Can TZOO weather a recessionIndex Update & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Acuitas Investments LLC Purchases 382,597 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Whale Trades: What is the dividend yield of Ligand Pharmaceuticals IncorporatedJuly 2025 Pullbacks & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Can Ligand Pharmaceuticals Incorporated outperform in the next rallyWeekly Stock Report & Entry Point Confirmation Signals - mfd.ru
Breakout Watch: Whats the profit margin of Ligand Pharmaceuticals IncorporatedMarket Rally & AI Driven Stock Movement Reports - baoquankhu1.vn
7,200 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by Pier 88 Investment Partners LLC - MarketBeat
Is Ligand Pharmaceuticals Incorporated in a bullish channelBull Run & AI Enhanced Execution Alerts - mfd.ru
Aug Opening: Can KRUS benefit from deglobalizationJuly 2025 Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn
Pullback Watch: Is Ligand Pharmaceuticals Incorporated a stock for growth or value investors2025 Pullback Review & Capital Efficiency Focused Ideas - baoquankhu1.vn
Massachusetts Financial Services Co. MA Buys 202,103 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Stephens Investment Management Group LLC Sells 50,271 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
SG Americas Securities LLC Has $2.08 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Could Be 37% Below Their Intrinsic Value Estimate - Yahoo Finance UK
Travere, Ligand Hammered On A Surprise Delay For Their Linchpin Drug - Investor's Business Daily
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13 - TechStock²
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap DownShould You Sell? - MarketBeat
Patterns Watch: Can Ligand Pharmaceuticals Incorporated stock continue upward trendJuly 2025 Breakouts & Safe Capital Growth Plans - Bộ Nội Vụ
Published on: 2026-01-13 22:28:13 - Bộ Nội Vụ
Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Yahoo Finance
Can Ligand Pharmaceuticals Incorporated stock rebound after recent weaknessJuly 2025 Fed Impact & Safe Entry Zone Tips - Улправда
Will Ligand Pharmaceuticals Incorporated stock remain a Wall Street favoriteTrade Risk Assessment & Daily Risk Controlled Trade Plans - Улправда
What technical signals suggest for Ligand Pharmaceuticals Incorporated stockJuly 2025 EndofMonth & High Win Rate Trade Tips - Улправда
Is Ligand Pharmaceuticals Incorporated stock attractive for hedge fundsQuarterly Trade Report & Entry Point Confirmation Signals - ulpravda.ru
Is Ligand Pharmaceuticals Incorporated stock a top momentum playExit Point & Free Long-Term Investment Growth Plans - Улправда
Is Ligand Pharmaceuticals Incorporated (LGDN) stock positioned for digital growth eraMarket Performance Summary & Weekly High Return Opportunities - Улправда
Is Ligand Pharmaceuticals Incorporated stock positioned well for digital economyJuly 2025 Snapshot & Weekly Setup with High ROI Potential - Улправда
Risk Recap: How Ligand Pharmaceuticals Incorporated stock reacts to oil pricesMarket Trend Review & Verified Stock Trade Ideas - Улправда
Ligand Pharmaceuticals director Kozarich sells $88,532 in stock By Investing.com - Investing.com South Africa
Book value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNYZ - TradingView — Track All Markets
1.12%
0.87%
자본화:
|
볼륨(24시간):